| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3063597 | Journal of Clinical Neuroscience | 2006 | 5 Pages |
Abstract
We report a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who showed high titers of anti-sulfated glucuronyl paragloboside (SGPG) IgM antibody without M-protein in serum. The patient was resistant to corticosteroids and immunosuppressants, but after administration of rituximab, clinical symptoms improved and the patient remained in a stable state for approximately 10 months. Rituximab may be a potent therapeutic option for refractory cases of CIDP irrespective of detectable M-protein in either serum or urine.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Takahisa Gono, Masayuki Matsuda, Yasuhiro Shimojima, Wataru Ishii, Kanji Yamamoto, Hiroshi Morita, Takao Hashimoto, Keiichiro Susuki, Nobuhiro Yuki, Shu-ichi Ikeda,